News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Genetown
What Sarepta Therapeutics’ Next Move Should Be
April 22, 2014
·
1 min read
Pharm Country
AVI BioPharma, Inc. CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company
June 2, 2011
·
1 min read
Drug Development
Novel ‘Antisense’ Therapies Protect Primates from Lethal Ebola and Marburg Viruses, AVI BioPharma, Inc. and US Army Study
August 23, 2010
·
1 min read
Biotech Beach
The Day In Review: Immunomedics, Inc. Sells Cancer Drug For $183 Million
May 10, 2006
·
1 min read
BioForest
Ocean Virus Identified In Human Blood Samples
March 23, 2006
·
1 min read
Biotech Versus Bioterror
October 19, 2005
·
1 min read
BioCapital
West Nile Drug Makers To End Research Due To Financial And Logistical Concerns
October 19, 2005
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan. 31, 2020
January 31, 2020
·
2 min read
Business
Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of Directors
January 13, 2020
·
5 min read
Genetown
Sarepta Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 6, 2020
·
1 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Dec. 31, 2019
December 31, 2019
·
2 min read
Business
Sarepta Therapeutics Announces Partnership with Roche in Territories Outside the United States for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy, SRP-9001
December 23, 2019
·
8 min read
Genetown
Sarepta Therapeutics Announces $250 Million of Non-Dilutive Senior Secured Loan Financing
December 13, 2019
·
4 min read
FDA
Sarepta Therapeutics Announces FDA Approval of VYONDYS 53™ (golodirsen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 53
December 12, 2019
·
12 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 29, 2019
November 29, 2019
·
2 min read
Business
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies
November 14, 2019
·
8 min read
Business
Sarepta Therapeutics Announces Third Quarter 2019 Financial Results and Recent Corporate Developments
November 7, 2019
·
26 min read
